Metabolic Management of insulin resistance and diabesity Filomena Trindade, MD, MPH Effect of Dietary Lipids on the Gut Microbiome: What Do We Know? Angela Zivkovic, PhD Aspirin Effectiveness and its Influence on Cardiovascular Risk Jeffrey Boone, M.D. The Microbiome and Cardiovascular Disease Thomas Sult, MD Pharmacological Principles of Treating Type 1 Diabetes Mellitus Blair Geho, MD, PhD The Human Microbiome in Health and Disease Robert Rountree, MD Tame the Flames of PCOS: A Unique Integrative Approach Felice Gersh, MD Why We Get Fat?: An Alternative Hypothesis of Obesity Gary Taubes « Page 1 » CME Webcasts Identifying Subclinical Cardiovascular Disease Aggressive Detection and Reversal of Heart Disease The Role of Adverse Pregnancy Outcomes in Heart Disease Prevention The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease Coronary Calcium Scanning: Role in Preventive Cardiology News You Can Use Albumin/Creatinine Ratio Helps Predict Heart Attack Risk in Patients with Type 1 Diabetes “Treat to Target” BP Study Halted Early Due to Reductions in CV Event and Death Rates “The Good Cholesterol” May Not be so Good After All Are Revolutionary New Drugs on the Horizon to Reduce CV Risks? Highlights of the New ACC/AHA Cardiovascular Risk Assessment Guidelines
